Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Lyrica to challenge antidepressants with new anxiety disorder approval

April 7, 2006 Research and Development

Pfizer's Lyrica is to go head to head with top-selling antidepressant drugs as it enters the market to treat generalised …
News

Novartis launch innovative leukaemia awareness campaign

March 30, 2006 Research and Development

Novartis has launched an innovative new campaign to raise awareness of leukaemia treatment among the UK's general practitioners; a move …
News

Novartis to develop Servier’s antidepressant for US

March 30, 2006 Research and Development

Novartis has signed a deal to develop and market Servier's new antidepressant and agomelatine for the US market.The drug has …
News

Novartis targets China with hepatitis drug

March 30, 2006 Research and Development

Novartis says trials of its new hepatitis drug in Chinese patients show it to be superior to standard treatment, in …
News

Taxotere approved for stomach cancer in US

March 28, 2006 Research and Development

Sanofi-Aventis has won US approval to market its drug Taxotere as a treatment for stomach cancer, and says it is …
News

Row over cardiovascular targets in new GP contract

March 24, 2006 Research and Development

Patient groups have condemned the new GP contract, saying it ignores a potentially life-threatening condition in tens of thousands of …
News

Investigators to examine Northwick Park trial safety

March 16, 2006 Research and Development

Two men involved in a UK clinical trial of new anti-inflammatory drug remain in a critical condition more than three …
News

World’s biggest DNA project launched

March 16, 2006 Research and Development DNA, MRC, UK Biobank, Wellcome

UK Biobank, the world’s largest and most detailed study of how genes, lifestyle and environment affect risks of developing disease, …
News

Deaths reported in dementia trial

March 16, 2006 Research and Development

Eleven patients have died in a study investigating Eisai/Pfizer's Aricept in the treatment of vascular dementia – but investigators say …
News

Crestor hailed as first drug to reverse cardiovascular disease

March 14, 2006 Research and Development

Researchers have hailed results from a new study of Crestor which shows it can reverse atherosclerosis, the furring up of …
News

Bright future for NicOx after Pfizer glaucoma deal

March 10, 2006 Research and Development

Shares in the French biotechnology company NicOx have soared after Pfizer snapped up the rights to its pipeline of ophthalmology …
News

Wyeth to open clinical trial ‘Super Centres’

February 23, 2006 Research and Development

Wyeth has unveiled plans to streamline its drug development operations by opening a network of clinical trial 'Super Centres' around …
News

Pfizer’s new blood infection drug Eraxis approved

February 23, 2006 Research and Development

Eraxis, a new treatment for potentially life-threatening fungal infections has been approved in the US.Pfizer's new antifungal is licensed to …
News

Tysabri trials restart after safety scare

February 20, 2006 Research and Development

Clinical trials of Tysabri, the troubled multiple sclerosis treatment, are to begin again in the US after the FDA gave …
News

Avastin trial recruitment suspended after patient deaths

February 16, 2006 Research and Development

Roche has stopped recruiting colon cancer patients who have undergone surgery to a trial of Avastin after four suddenly died.The …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025